Lung cancer incidence in never smokers.

PURPOSE Lung cancer is a leading cause of cancer death worldwide. Although smoking remains the predominant cause of lung cancer, lung cancer in never smokers is an increasingly prominent public health issue. However, data on this topic, particularly lung cancer incidence rates in never smokers, are limited. METHODS We reviewed the existing literature on lung cancer incidence and mortality rates among never smokers and present new data regarding rates in never smokers from the following large, prospective cohorts: Nurses' Health Study; Health Professionals Follow-Up Study; California Teachers Study; Multiethnic Cohort Study; Swedish Lung Cancer Register in the Uppsala/Orebro region; and First National Health and Nutrition Examination Survey Epidemiologic Follow-Up Study. RESULTS Truncated age-adjusted incidence rates of lung cancer among never smokers age 40 to 79 years in these six cohorts ranged from 14.4 to 20.8 per 100,000 person-years in women and 4.8 to 13.7 per 100,000 person-years in men, supporting earlier observations that women are more likely than men to have non-smoking-associated lung cancer. The distinct biology of lung cancer in never smokers is apparent in differential responses to epidermal growth factor receptor inhibitors and an increased prevalence of adenocarcinoma histology in never smokers. CONCLUSION Lung cancer in never smokers is an important public health issue, and further exploration of its incidence patterns, etiology, and biology is needed.

[1]  R C Brownson,et al.  Lung cancer in nonsmoking women. Histology and survival patterns , 1995, Cancer.

[2]  Hoda Anton-Culver,et al.  High breast cancer incidence rates among California teachers: results from the California Teachers Study (United States) , 2002, Cancer Causes & Control.

[3]  Xifeng Wu,et al.  Metabolic gene polymorphisms and lung cancer risk in non-smokers. An update of the GSEC study. , 2005, Mutation research.

[4]  G. Bepler,et al.  Improved survival in never-smokers vs current smokers with primary adenocarcinoma of the lung. , 2004, Chest.

[5]  N. Battersby,et al.  Smoking verification and the risk of myocardial infarction , 2004, Journal of epidemiology and community health.

[6]  Chris Bain,et al.  Lung cancer rates in men and women with comparable histories of smoking. , 2004, Journal of the National Cancer Institute.

[7]  E. van Marck,et al.  Prognostic value of smoking status in operated non-small cell lung cancer. , 2005, Lung cancer.

[8]  D. Schwartz,et al.  CYP1A1 and CYP1B1 polymorphisms and risk of lung cancer among never smokers: a population-based study. , 2005, Carcinogenesis.

[9]  W. Willett,et al.  Prospective study of fruit and vegetable consumption and risk of lung cancer among men and women. , 2000, Journal of the National Cancer Institute.

[10]  D. West,et al.  Cancer Surveillance Research: a Vital Subdiscipline of Cancer Epidemiology , 2005, Cancer Causes & Control.

[11]  E. Gottschall,et al.  Occupational and Environmental Thoracic Malignancies , 2002, Journal of thoracic imaging.

[12]  H. Wichmann,et al.  The cumulative risk of lung cancer among current, ex- and never-smokers in European men , 2004, British Journal of Cancer.

[13]  R. Wilson,et al.  Use of cigarette-smoking history to estimate the likelihood of mutations in epidermal growth factor receptor gene exons 19 and 21 in lung adenocarcinomas. , 2006, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[14]  S. Ou,et al.  bronchioloalveolar carcinoma : Improvement in survival after release of the 1999 WHO classification of lung tumors , 2006 .

[15]  E. Fontham,et al.  Family history of cancer and risk of lung cancer among lifetime nonsmoking women in the United States. , 1996, American journal of epidemiology.

[16]  Kevin Carroll,et al.  Gefitinib plus best supportive care in previously treated patients with refractory advanced non-small-cell lung cancer: results from a randomised, placebo-controlled, multicentre study (Iressa Survival Evaluation in Lung Cancer) , 2005, The Lancet.

[17]  Daniel S. Miller,et al.  Annual report to the nation on the status of cancer, 1973-1996, with a special section on lung cancer and tobacco smoking. , 1999, Journal of the National Cancer Institute.

[18]  R. Dersimonian,et al.  Serum cotinine concentration and self-reported smoking during pregnancy. , 1998, American journal of epidemiology.

[19]  K. Syrjänen,et al.  Detection and expression of human papillomavirus oncogenes in non-small cell lung cancer. , 2006, Oncology reports.

[20]  Guillermo Marshall,et al.  Lung Cancer and Arsenic Concentrations in Drinking Water in Chile , 2000, Epidemiology.

[21]  H. Morgenstern,et al.  Ecologic studies in epidemiology: concepts, principles, and methods. , 1995, Annual review of public health.

[22]  E. Wynder,et al.  Lung cancer pathology in smokers, ex-smokers and never smokers. , 1995, Cancer letters.

[23]  N. Hanna Never smokers and lung cancer risk: A case-control study of epidemiological factors , 2007 .

[24]  P. Hainaut,et al.  TP53 and KRAS mutation load and types in lung cancers in relation to tobacco smoke: distinct patterns in never, former, and current smokers. , 2005, Cancer research.

[25]  C. Weinberg,et al.  Indoor Radon and Lung Cancer Risk in Connecticut and Utah , 2006, Journal of toxicology and environmental health. Part A.

[26]  L. Tanoue,et al.  Erlotinib in Previously Treated Non-Small-Cell Lung Cancer , 2007 .

[27]  D. Christiani,et al.  Lung adenocarcinoma and human papillomavirus infection , 2004, Cancer.

[28]  E. G. Letourneau,et al.  A Combined Analysis of North American Case-Control Studies of Residential Radon and Lung Cancer , 2006, Journal of toxicology and environmental health. Part A.

[29]  R. Brownson,et al.  Family history of cancer and risk of lung cancer in lifetime non-smokers and long-term ex-smokers. , 1997, International journal of epidemiology.

[30]  C. Harris,et al.  Radon, secondhand smoke, glutathione‐S‐transferase M1 and lung cancer among women , 2006, International journal of cancer.

[31]  Karl-Heinz Jöckel,et al.  Secondhand smoke exposure in adulthood and risk of lung cancer among never smokers: A pooled analysis of two large studies , 2004, International journal of cancer.

[32]  M. Thornquist,et al.  Prior Lung Disease and Risk of Lung Cancer in a Large Prospective Study , 2004, Cancer Causes & Control.

[33]  F. Clavel-Chapelon,et al.  Environmental tobacco smoke and risk of respiratory cancer and chronic obstructive pulmonary disease in former smokers and never smokers in the EPIC prospective study , 2005, BMJ : British Medical Journal.

[34]  S. Mayne,et al.  Previous lung disease and risk of lung cancer among men and women nonsmokers. , 1999, American journal of epidemiology.

[35]  G. Giovino,et al.  Surveillance for selected tobacco-use behaviors--United States, 1900-1994. , 1994, MMWR. CDC surveillance summaries : Morbidity and mortality weekly report. CDC surveillance summaries.

[36]  R. Field,et al.  Occupation and Lung Cancer in Non-Smokers , 2003, Reviews on environmental health.

[37]  B. Henderson,et al.  Previous lung disease and risk of lung cancer among lifetime nonsmoking women in the United States. , 1995, American journal of epidemiology.

[38]  J. Manson,et al.  The Nurses' Health Study: 20-year contribution to the understanding of health among women. , 1997, Journal of women's health.

[39]  P. Brennan,et al.  Incidence of lung cancer in a large cohort of non‐smoking men from Sweden , 2001, International journal of cancer.

[40]  Anthony J Alberg,et al.  Epidemiology of lung cancer: looking to the future. , 2005, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[41]  B. Armstrong Occupation and lung cancer , 1985, The Medical journal of Australia.

[42]  R Doll,et al.  Radon in homes and risk of lung cancer: collaborative analysis of individual data from 13 European case-control studies , 2004, BMJ : British Medical Journal.

[43]  L. Daly,et al.  Simple SAS macros for the calculation of exact binomial and Poisson confidence limits. , 1992, Computers in biology and medicine.

[44]  C. Leroux,et al.  Pathology of human bronchioloalveolar carcinoma and its relationship to the ovine disease. , 2003, Current topics in microbiology and immunology.

[45]  Michael J Thun,et al.  Lung cancer death rates in lifelong nonsmokers. , 2006, Journal of the National Cancer Institute.

[46]  S Sone,et al.  Growth rate of small lung cancers detected on mass CT screening. , 2000, The British journal of radiology.

[47]  K. Sridhar,et al.  Present and past smoking history and other predisposing factors in 100 lung cancer patients. , 1992, Chest.

[48]  A. Jemal,et al.  Recent trends in lung cancer mortality in the United States. , 2001, Journal of the National Cancer Institute.

[49]  Richard Doll,et al.  Smoking, smoking cessation, and lung cancer in the UK since 1950: combination of national statistics with two case-control studies , 2000, BMJ : British Medical Journal.

[50]  E. Rimm,et al.  Effectiveness of various mailing strategies among nonrespondents in a prospective cohort study. , 1990, American journal of epidemiology.

[51]  N. Hanna Ethnic and Racial Differences in the Smoking-Related Risk of Lung Cancer , 2007 .

[52]  A. Jemal,et al.  Contemporary Lung Cancer Trends among U.S. Women , 2005, Cancer Epidemiology Biomarkers & Prevention.

[53]  J. Minna,et al.  Distinct Epidermal Growth Factor Receptor and KRAS Mutation Patterns in Non–Small Cell Lung Cancer Patients with Different Tobacco Exposure and Clinicopathologic Features , 2006, Clinical Cancer Research.

[54]  E. Perez-stable,et al.  Misclassification rates for current smokers misclassified as nonsmokers. , 1998, American journal of public health.

[55]  S. Kam,et al.  Polymorphisms in the hMSH2 Gene and the Risk of Primary Lung Cancer , 2006, Cancer Epidemiology Biomarkers & Prevention.

[56]  Zhong Wen-zhao,et al.  Erlotinib in Lung Cancer - Molecular and Clinical Predictors of Outcome , 2006 .

[57]  Y. Hsueh,et al.  Ingested arsenic, cigarette smoking, and lung cancer risk: a follow-up study in arseniasis-endemic areas in Taiwan. , 2004, JAMA.

[58]  H. Brenner,et al.  Calculating age-adjusted cancer survival estimates when age-specific data are sparse: an empirical evaluation of various methods , 2006, British Journal of Cancer.

[59]  H. Wakelee,et al.  Lung cancer in women: exploring sex differences in susceptibility, biology, and therapeutic response. , 2006, Clinical lung cancer.

[60]  N. Hanna,et al.  EGF Receptor Gene Mutations Are Common in Lung Cancers From “Never Smokers” and Are Associated With Sensitivity of Tumors to Gefitinib and Erlotinib , 2006 .

[61]  A. Jemal,et al.  Cancer Statistics, 2006 , 2006, CA: a cancer journal for clinicians.

[62]  M. Ando,et al.  Updated Information on Risk Factors for Lung Cancer: Findings from the JACC Study , 2005, Journal of epidemiology.

[63]  W. Thomson Occupation and lung cancer. , 1971, Nursing times.

[64]  D O Stram,et al.  A multiethnic cohort in Hawaii and Los Angeles: baseline characteristics. , 2000, American journal of epidemiology.

[65]  G. Pershagen,et al.  A European validation study of smoking and environmental tobacco smoke exposure in nonsmoking lung cancer cases and controls , 1998, Cancer Causes & Control.

[66]  Fredrik Nyberg,et al.  Contribution of environmental factors to cancer risk. , 2003, British medical bulletin.

[67]  G. Giovino,et al.  Factors associated with discrepancies between self-reports on cigarette smoking and measured serum cotinine levels among persons aged 17 years or older: Third National Health and Nutrition Examination Survey, 1988-1994. , 2001, American journal of epidemiology.

[68]  L. Marchand,et al.  Polymorphisms in CYP1A1, GSTM1, GSTT1 and lung cancer below the age of 45 years. , 2003, International journal of epidemiology.

[69]  P. Taylor,et al.  Intake of vitamins E, C, and A and risk of lung cancer. The NHANES I epidemiologic followup study. First National Health and Nutrition Examination Survey. , 1997, American journal of epidemiology.

[70]  P. Validire,et al.  Differential expression of biomarkers in lung adenocarcinoma: a comparative study between smokers and never-smokers. , 2005, Annals of oncology : official journal of the European Society for Medical Oncology.

[71]  S. Land,et al.  GSTM1, GSTT1 and GSTP1 polymorphisms, environmental tobacco smoke exposure and risk of lung cancer among never smokers: a population-based study. , 2004, Carcinogenesis.